Ajani JA - Search Results

1

Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin.

Rich TA, Ajani JA, Morrison WH, Ota D, Levin B. Rich TA, et al. Among authors: ajani ja. Radiother Oncol. 1993 Jun;27(3):209-15. doi: 10.1016/0167-8140(93)90076-k. Radiother Oncol. 1993. PMID: 8210457

2

Phase II trial of fazarabine in advanced colorectal carcinoma.

Hubbard KP, Daugherty K, Ajani JA, Pazdur R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: ajani ja. Invest New Drugs. 1992 Apr;10(1):39-42. doi: 10.1007/BF01275479. Invest New Drugs. 1992. PMID: 1376722 Clinical Trial.

3

Phase II study of didemnin B in advanced colorectal cancer.

Jones DV Jr, Ajani JA, Blackburn R, Daugherty K, Levin B, Patt YZ, Abbruzzese JL. Jones DV Jr, et al. Among authors: ajani ja. Invest New Drugs. 1992 Aug;10(3):211-3. doi: 10.1007/BF00877248. Invest New Drugs. 1992. PMID: 1428730 Clinical Trial.

4

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: ajani ja. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

5

Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.

Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B, Mountain C. Ajani JA, et al. Eur J Cancer. 1992;28A(4-5):880-4. doi: 10.1016/0959-8049(92)90140-w. Eur J Cancer. 1992. PMID: 1524915

6

Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.

Grossie VB Jr, Nishioka K, Ajani JA, Ota DM. Grossie VB Jr, et al. Among authors: ajani ja. J Surg Oncol. 1992 Jul;50(3):161-7. doi: 10.1002/jso.2930500307. J Surg Oncol. 1992. PMID: 1619938

7

Histologic observations and P-glycoprotein expression in gastric and esophageal adenocarcinomas treated with preoperative chemotherapy.

Robey-Cafferty SS, Ajani JA, Ota DM, Roth JA, Bruner JM. Robey-Cafferty SS, et al. Among authors: ajani ja. Arch Pathol Lab Med. 1991 Aug;115(8):807-12. Arch Pathol Lab Med. 1991. PMID: 1713759

8

A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.

Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, Hallinan R, Levin B. Pazdur R, et al. Among authors: ajani ja. Cancer. 1992 Feb 15;69(4):878-82. doi: 10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0. Cancer. 1992. PMID: 1735078 Clinical Trial.

9

Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Wiseman C, Lenado-Lee MA, Patt YZ, Krakoff IH. Ajani JA, et al. Invest New Drugs. 1991 Aug;9(3):257-9. doi: 10.1007/BF00176979. Invest New Drugs. 1991. PMID: 1783525 Clinical Trial.

10

Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.

Grossie VB Jr, Ota DM, Ajani JA, Nishioka K. Grossie VB Jr, et al. Among authors: ajani ja. Invest New Drugs. 1991 Nov;9(4):321-6. doi: 10.1007/BF00183572. Invest New Drugs. 1991. PMID: 1804805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters